Skip to content

Clinical trials

Phase 4 Carcinoma trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Carcinoma Phase: Phase 4 Clear all

14 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20031
20071
20082
20091
20121
20141
20202
20212
20221
20232

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed11
Unknown status2
Recruiting1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Pfizer2
AstraZeneca1
Celgene1
Cytori Therapeutics1
Hong Kong Children's Hospital1
Jemincare1
National Institute of Neurological Disorders and Stroke (NINDS)1
Novartis Pharmaceuticals1
ShuGuang Hospital1
Sirtex Medical1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Carcinoma14
Carcinoma, Non-Small-Cell Lung4
Neoplasms4
Adenocarcinoma2
Basal Cell Carcinoma2
Breast Neoplasms2
Carcinoma, Squamous Cell2
Lung Neoplasms2
Adenoma1
Brain Neoplasms1

Trials

Showing 1 to 14 of 14. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.